Abstract: The present disclosure provides methods and apparatuses for acquiring route popularity in road networks.

Abstract: The present disclosure provides methods and an apparatuses for acquiring route popularity in road networks. One exemplary method includes: acquiring a plurality of points of interest (POIs) included in road networks and positioning data of a plurality of positioning terminals; mapping the positioning data of each positioning terminal to POIs included in the road networks to obtain one or more POIs associated with the positioning terminal; acquiring a travel route map of the positioning terminal according to the one or more POIs associated with the positioning terminal; acquiring a preferred travel route of the positioning terminal according to the travel route map of the positioning terminal; and aggregating the preferred travel routes of the plurality of positioning terminals to obtain a route popularity distribution map of the road networks.

Abstract: Disclosed herein are methods, systems and devices for evaluating a health condition of an Internet user. In one embodiment, the method comprises acquiring Internet activity data associated with a plurality of users, the plurality of users including a first user; selecting a set of sample users from the plurality of users based on a plurality of specified Internet activities identified in Internet activity data associated with the first user; extracting characteristic data for the first user and the set of sample users from the Internet activity data; utilizing the characteristic data as at least one parameter of a health index calculation model; and calculating a health index for the first user based on the health index calculation model.

Abstract: The present invention is to providing a new preparation including complex of a medical compound with lutein, astaxanthin and antioxidant. The new preparation includes stabilized liposome preparation, sustained release preparation and polymeric micelles preparation which used as delivery systems for lutein, astaxanthin and antioxidant. The new preparation significantly increases bioavailability of lutein and astaxanthin and uses for treatment and prevention of eyes and other disease.

Abstract: The present invention is to providing a new preparation including complex of a medical compound with lutein, astaxanthin and antioxidant. The new preparation includes stabilized liposome preparation, sustained release preparation and polymeric micelles preparation which used as delivery systems for lutein, astaxanthin and antioxidant. The new preparation significantly increases bioavailability of lutein and astaxanthin and uses for treatment and prevention of eyes and other disease.

Abstract: The present invention is providing a new sustained release drug preparation comprising such and inclusion complex of a medical compound with safe botanic drug (SBD), which sustains or retards the dissolution and release of the SBD at a controlled rate from the inclusion complex and hence from the drug preparation containing the SBD, so as to maintain the concentration of the SBD in blood at an effective level for prolonged time. SBD contains Kuguasu (KU) and saponins of Kugua (SAK). SBD is very safe and it is used for treating and preventing diabetes.

Abstract: The present invention is providing a new sustained release drug preparation comprising such and inclusion complex of a medical compound with safe botanic drug (SBD), which sustains or retards the dissolution and release of the SBD at a controlled rate from the inclusion complex and hence from the drug preparation containing the SBD, so as to maintain the concentration of the SBD in blood at an effective level for prolonged time. SBD contains Kuguasu (KU) and saponins of Kugua (SAK). SBD is very safe and it is used for treating and preventing diabetes.

Abstract: A safe pharmaceutical composition for treatment of cancer contains Homoharringtonine (HHT). The new methods of process for producing HHT include culture plant tissue and semisynthesis.

Abstract: Commands from a central controller of a printing system are received at a first component of a printing system. The commands include component ready commands and non-component ready commands. The component ready commands are routed unaltered to a second component of the printing system.

Abstract: A service station for a print system includes a dedicated controller and a network interface configured to couple the service station to a central controller of the print system and to other components of the print system over a network. The dedicated controller is configured to allow the service station to perform a task in response to receiving a command indicative of the task over the network from the central controller of the print system without the central controller knowing the details of the task.

Abstract: The present invention provides a new method for extracting Homoharringtonine (HHT) by culture cells or culture plant tissues. Also, disclosed are methods of obtaining HHT from semi-synthesis and biosynthesis. The present invention disclosed that HHT combined with some botanical drugs could induce cancer cells to resemble normal cells. To add some botanical drugs combined with HHT can significantly increase anticancer effects of HHT. These drugs include Matrine (MAT), Guanzhongsu (GU), Maidongsu (MU), and Indirubin (IND). The experimental data showed that above drugs have strong synergisms effects for treating leukemia and other cancer cells and more safe.

Abstract: The present invention provides a new method for extracting Homoharringtonine (HHT) by culture cells or culture plant tissues. Also, disclosed are methods of obtaining HHT from semi-synthesis and biosynthesis. The present invention disclosed that HHT combined with some botanical drugs could induce cancer cells to resemble normal cells. To add some botanical drugs combined with HHT can significantly increase anticancer effects of HHT. These drugs include Matrine (MAT), Guanzhongsu (GU), Maidongsu (MU), and Indirubin (IND). The experimental data showed that above drugs have strong synergisms effects for treating leukemia and other cancer cells and more safe.

Abstract: This invention relates in general to the treatment of diabetes and cardiovascular disease. The pharmaceutical composition is composed of two ingredients: pumpkin polysaccharide and corn saponins and method of making the same.

Abstract: A printer with a carriage adapted to receive a printhead capable of printing an ink at an effective nozzle density along a medium advance axis. The printhead includes a plurality of substantially parallel columnar arrays of nozzles, each columnar array having an actual nozzle density along the medium advance axis less than the effective nozzle density. An alignment structure in the carriage orients the printhead to print at the actual nozzle density along the medium advance axis such that individual nozzles in different ones of the columnar arrays can deposit ink on a print medium in a row substantially orthogonal to the medium advance axis.

Abstract: A pharmaceutical composition for prevention and treatment of cancer, cardiovascular disease and antioxidation contains resveratol. The new method of process for producing resveratol is extracted resveratol from oil residue and stems of peanuts or stems of other cheap herbs. Derivates of resveratol include procyanidins, polydatin, peceid, anthraglycoside, emodin, chrysophanol and quercetin.

Abstract: Disclosed are systems and methods for ink management utilizing a master controller, which receives configuration information from one or more ink pens, reservoirs, printheads, or ink level measurement devices. The controller receives master controller commands; reads data from system sensors; reads and writes data to and from smart chips associated with elements in the system and a non-volatile memory associated with an ink management controller; and independently takes action in response to data from a smart chip or sensor.

Abstract: The present invention relates to a new technique formed from polysaccharides of kelp (PK), which has function of anticancer and increasing immunity, and new nanoparticles (NP) and special liposome (SSL), which contained natural anticancer drug their preparation. Also, the present invention is aimed at the overall improvement of therapeutic efficacy of anticancer drugs, including Homoharringtonine (HHT), Curcumol (CUR), Eelemene (ELE) and Camptothecin (CPT) by NP and SSL. NP improves the anticancer therapeutic efficacy of HHT, CUR, ELE and CPT by using PK as polymer. PK can improve the anticancer therapeutic index and decrease side effect of free anticancer drugs. Also, PK has the function of increasing immunity.

Abstract: The present invention related to the natural drug of Homoharringtonine (HHT) combined with other ingredients which include Matrine (MAT), Apigenin (APN), Yejuhua lactone (YLE), Lipopolysaccharide of Kelp (LIK), Puerarin (PUN) and Indirubin (IND) for diverting human cancer cells to closely normal cells, inducing apoptosis of cancer cells and inhibiting cancer cells.

Abstract: This invention relates to a new method of isolating soybean isoflavone (SIS) from soybean residue and leaves Soybean isoflavone can treat and prevent cardiovascular disease, menopausal and climacteric syndrome and increase immune function

Abstract: A printer with a carriage adapted to receive a printhead capable of printing an ink at an effective nozzle density along a medium advance axis. The printhead includes a plurality of substantially parallel columnar arrays of nozzles, each columnar array having an actual nozzle density along the medium advance axis less than the effective nozzle density. An alignment structure in the carriage orients the printhead to print at the actual nozzle density along the medium advance axis such that individual nozzles in different ones of the columnar arrays can deposit ink on a print medium in a row substantially orthogonal to the medium advance axis.